Instituto Nacional De Cardiologia Ignacio Chavez
Clinical trials sponsored by Instituto Nacional De Cardiologia Ignacio Chavez, explained in plain language.
-
Could a diabetes pill protect heart attack patients during emergency artery repair?
Disease control OngoingThis study tests whether empagliflozin, a diabetes drug, can reduce the risk of 'no-reflow'—a dangerous complication where blood flow isn't fully restored after angioplasty for a heart attack. About 162 adults with ST-elevation heart attacks will receive either the drug or a plac…
Phase: PHASE2 • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Disease control
Last updated May 25, 2026 15:02 UTC
-
Heart study: can a simple shot improve wrist artery access?
Symptom relief TerminatedThis study tests whether a small shot of nitroglycerin under the skin can widen the wrist artery, making it easier for doctors to insert a tube for heart procedures. It involves 1,400 adults with coronary artery disease who need a heart catheterization. The goal is to reduce the …
Phase: PHASE4 • Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez • Aim: Symptom relief
Last updated May 25, 2026 15:06 UTC